(Q28359800)

1

0 references

S M Shah

2

0 references

D J Spalton

3

0 references

C Bradbeer

4

0 references

R N Thin

British Journal of Ophthalmology

5

0 references

language of work or name

English

0 references

publication date

November 1987

0 references

published in

0 references

volume

71

0 references

issue

11

0 references

page(s)

810-6

0 references

cites work

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS)

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Herpes zoster ophthalmicus and acquired immune deficiency syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Concurrent herpes simplex and cytomegalovirus retinitis and encephalitis in the acquired immune deficiency syndrome (AIDS).

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Foscarnet for cytomegalovirus infections

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1041317

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

2 June 2018

1 reference

12 December 2020

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

12 December 2020

Foscarnet for cytomegalovirus pneumonitis

1 reference

12 December 2020

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

12 December 2020

9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Foscarnet for cytomegalovirus retinitis

1 reference

12 December 2020

Ocular Disorders Associated with a new Severe Acquired Cellular Immunodeficiency Syndrome

1 reference

12 December 2020

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent

1 reference

12 December 2020

Acquired immune deficiency syndrome. Ocular manifestations

1 reference

12 December 2020

Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients

1 reference

12 December 2020